Evidence map›Paper›PMID 33184077›Full record

ArticleBMJ open2020

Translating the Symptom Screening in Paediatrics Tool (SSPedi) into North American Spanish and Among Spanish-speaking children receiving cancer treatments: evaluating understandability and cultural relevance in a multiple-phase descriptive study.

Erin Plenert, Allison Grimes, Aaron Sugalski, Anne-Marie Langevin, Dominica Nieto, Carmen Salaverria, Sergio Gomez, Gisela Gonzalez, Gisela D'Angelo, Lee Dupuis and 1 more

Abstract read
In one paragraph

Article in BMJ open, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Trial
  2. Language understanding and preferences when reporting symptoms for pediatric patients receiving cancer treatments and their guardians.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Erin PlenertCHES, Hospital for Sick Children SickKids Learning Institute, Toronto, Ontario, Canada.
Allison GrimesDivision of Hematology-Oncology, University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA.
Aaron SugalskiDivision of Hematology-Oncology, University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA.
Anne-Marie LangevinDivision of Hematology-Oncology, University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA.
Dominica NietoDivision of Hematology-Oncology, University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA.
Carmen SalaverriaDepartment of Oncology, Hospital Nacional De Ninos Benjamin Bloom, San Salvador, El Salvador.
Sergio GomezStem Cell Transplantation Unit, Hospital de Niños Sor María Ludovica, La Plata, Argentina.
Gisela GonzalezStem Cell Transplantation Unit, Hospital de Niños Sor María Ludovica, La Plata, Argentina.
Gisela D'AngeloStem Cell Transplantation Unit, Hospital de Niños Sor María Ludovica, La Plata, Argentina.
Lee DupuisUniversity of Toronto Leslie Dan Faculty of Pharmacy, Toronto, Ontario, Canada.
Lillian SungCHES, Hospital for Sick Children SickKids Learning Institute, Toronto, Ontario, Canada lillian.sung@sickkids.ca.ORCID 0000-0003-0951-3091

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesSymptom screening is important to achieving symptom control. Symptom Screening in Paediatrics Tool (SSPedi) is validated for English-speaking children. Objectives were to translate SSPedi into Spanish, and to evaluate the understandability and cultural relevance of the translated version among Spanish-speaking children with cancer and paediatric haematopoietic stem cell transplant recipients.

methodsWe conducted a multiphase, descriptive study to translate SSPedi into Spanish. The first step was to determine whether one Spanish version would be appropriate for both North America and Argentina. Once this decision was made, forward and backward translations were performed. The translated version was evaluated by Spanish-speaking children 8-18 years of age receiving cancer treatments. PRIMARY AND SECONDARY OUTCOME MEASURES: Primary outcome was child self-reported difficulty with understanding of the entire instrument and each symptom using a 5-point Likert scale. Secondary outcomes were incorrect understanding of SSPedi items identified by cognitive interviews with the children using a 4-point Likert scale and cultural relevance, which was assessed qualitatively.

resultsThis report focuses on North American Spanish as a separate version will be required for Argentinian Spanish SSPedi based on different common vocabulary and grammatical structure. There were 20 children from Toronto and San Antonio included in cognitive interviews. The most common types of Spanish spoken were Mexican (13, 65%), Central American (2, 10%) and South American (2, 10%). No child reported that it was hard or very hard to complete Spanish SSPedi. Changes to the instrument itself were not required based on understanding or cultural relevance.

conclusionsWe translated and finalised Spanish SSPedi appropriate for use in North America. Future research will translate and evaluate SSPedi for use in Argentina and other Spanish-speaking countries.

Indexed as

NeoplasmsPediatricsArgentinaChildEarly Detection of CancerHumansNorth AmericaPsychometricsSurveys and QuestionnairesSymptom AssessmentTranslatingbone marrow transplantationpaediatric oncology

Identifiers

PMID33184077
PMCPMC7662419

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.